Open AccessDesloratadine-Eudragit<sup>®</sup> RS100 Nanoparticles: Formulation and Characterization
Author(s) -
Evrim Yenilmez
Publication year - 2017
Publication title -
turkish journal of pharmaceutical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.241
H-Index - 14
eISSN - 2148-6247
pISSN - 1304-530X
DOI - 10.4274/tjps.52523
Subject(s) - desloratadine , nanoparticle , characterization (materials science) , nuclear chemistry , chemistry , materials science , pharmacology , nanotechnology , medicine
The objective of the present study was to formulate Desloratadine-Eudragit ® RS100 nanoparticles and investigate the characteristics of the prepared nanoparticles.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom